July 22 (Reuters) - Pfizer said on Wednesday the U.S. Food and Drug Administration has granted priority review to its ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with ...

President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to ...

Once men with metastatic hormone-sensitive prostate cancer start androgen deprivation therapy (ADT) and an androgen receptor pathway inhibitor (ARPI), the conventional thinking is that they stay on ...

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, today announced a strategic collaboration with Bayer to evaluate ...

Stay connected via Google News Scientists at Umeå University in Sweden and partner institutions have developed an ...

A fully human therapeutic antibody has been shown to stop prostate tumor growth and metastasis via a novel mechanisms of ...

Recently published Metastatic Castration-resistant Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, metastatic castration-resistant ...

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...

Clinicians report that early AKT inhibition side effects are manageable, allowing four out of five patients to maintain ...

When a cancer cell leaves the original tumor to spread to a new, faraway location, it first has to survive what most cells ...

Kairos Pharma inks strategic collaboration with Bayer to enhance Xofigo activity in metastatic prostate cancer: Los Angeles Friday, July 24, 2026, 18:00 Hrs [IST] Kairos Pharma, L ...